Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sarai Solano"'
Autor:
Carlos Alfaro, Natalia Suárez, Ivan Martínez-Forero, Asís Palazón, Ana Rouzaut, Sarai Solano, Esperanza Feijoo, Alfonso Gúrpide, Elixabet Bolaños, Lorena Erro, Juan Dubrot, Sandra Hervás-Stubbs, Alvaro Gonzalez, Jose Luis Perez-Gracia, Ignacio Melero
Publikováno v:
PLoS ONE, Vol 6, Iss 3, p e17922 (2011)
BACKGROUND: Interleukin-8 (IL-8, CXCL8) is readily produced by human malignant cells. Dendritic cells (DC) both produce IL-8 and express the IL-8 functional receptors CXCR1 and CXCR2. Most human colon carcinomas produce IL-8. IL-8 importance in malig
Externí odkaz:
https://doaj.org/article/9428cbf661274a5ea5ad563c567ea690
Autor:
Sarai Solano, Arantza Azpilikueta, Carmen Berasain, Asis Palazon, Carlos Alfaro, Oihana Murillo, Pedro Berraondo, Ignacio Melero, Ainhoa Arina, Maria C. Ochoa, Jose Luis Perez-Gracia, Juan Dubrot, Sandra Hervas-Stubbs, Izaskun Gabari
Publikováno v:
European Journal of Immunology. 39:2424-2436
Anti-CD137 mAb are capable of inducing tumor rejection in several syngeneic murine tumor models and are undergoing clinical trials for cancer. The anti-tumor effect involves co-stimulation of tumor-specific CD8(+) T cells. Whether antigen cross-prese
Autor:
Lorena Erro, Natalia Suarez, Ignacio Melero, Sarai Solano, Alfonso Gurpide, Asis Palazon, Juan Dubrot, José María López-Picazo, Carlos Alfaro, E Grande-Pulido, Alvaro Gonzalez, Sandra Hervas-Stubbs, Jose Luis Perez-Gracia
Publikováno v:
British Journal of Cancer
Vascular endothelial growth factor (VEGF) inhibits differentiation and maturation of dendritic cells (DC), suggesting a potential immunosuppressive role for this proangiogenic factor. Bevacizumab, sorafenib and sunitinib target VEGF-mediated angiogen
Autor:
Elixabet Bolaños, Jose Luis Perez-Gracia, Carlos Alfaro, Sandra Hervas-Stubbs, Lorena Erro, Asis Palazon, Juan Dubrot, Ana Rouzaut, Alvaro Gonzalez, Ignacio Melero, Ivan Martinez-Forero, Alfonso Gurpide, Sarai Solano, Esperanza Feijoo, Natalia Suarez
Publikováno v:
PLoS ONE
PLoS ONE, Vol 6, Iss 3, p e17922 (2011)
Dadun. Depósito Académico Digital de la Universidad de Navarra
instname
PLoS ONE; Vol 6
PLoS ONE, Vol 6, Iss 3, p e17922 (2011)
Dadun. Depósito Académico Digital de la Universidad de Navarra
instname
PLoS ONE; Vol 6
BACKGROUND: Interleukin-8 (IL-8, CXCL8) is readily produced by human malignant cells. Dendritic cells (DC) both produce IL-8 and express the IL-8 functional receptors CXCR1 and CXCR2. Most human colon carcinomas produce IL-8. IL-8 importance in malig
Autor:
Sarai Solano, Jose Luis Perez-Gracia, Carlos Alfaro, Sandra Hervas-Stubbs, Arantza Azpilikueta, Maria C. Ochoa, Juan Dubrot, Anjana Gupta, Ignacio Melero, Ainhoa Arina, Brandon McCluskey, Asis Palazon, Oihana Murillo, Babatunde O. Oyajobi
Purpose: Eradication of post-treatment residual myeloma cells is needed to prevent relapses, and immunostimulatory monoclonal antibodies (mAb) such as anti-CD137, CTLA-4, CD40, etc., which enhance the immune response against malignancies, represent a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72f63bfbddbb15e1a64ca1626090d4fc
https://hdl.handle.net/10171/21771
https://hdl.handle.net/10171/21771